The death toll in the Ebola outbreak in the Congo continues to climb. As of April 3, 135 cases have been reported with 121 deaths in the districts of Mbomo and Kelle in the forest region of Cuvette-Ouest---about 440 miles north of the capital Brazzaville. Transmission of the virus to people is thought to be linked to the consumption of infected monkey meat. The outbreak is the second reported in little over a year in the remote forest region of the central African country. 13 cases have been laboratory confirmed, and 122 epidemiologically linked. Encouragingly, only 34 contacts are being followed-up compared with an earlier report where 79 contacts were followed up, thus suggesting the outbreak is slowing down and becoming under control. Ian Simpson (WHO) told *TLID* that, "the outbreak team has been under so much pressure from severe acute respiratory syndrome (SARS) that an Ebola outbreak which would normally get 95% of their attention is sadly now getting about 5%".

A measles outbreak was reported in a village 20 km east of Suleymaniah, in the north of Iraq. The outbreak was confirmed by a team from the WHO. As of April 8, 28 children between the ages of 6 and 15 are currently affected. Measles is one of the main causes of the high rate of infant mortality in Iraq. WHO and UNICEF are now considering measures including an emergency measles vaccination campaign. This would mean going from door to door in the surrounding villages to protect other children. However, since schools are currently closed, the risk of infection is smaller. Between January and March of this year, 150000 measles vaccines were shipped to the Northern governorates and a routine vaccination campaign for children between 9 months and 5 years was carried out. Under normal circumstances this shipment would have been sufficient for the next 10 months. However, more measles vaccine is now needed for children aged between 6 and 15 who are at a high risk of being infected.

A large outbreak of human enterovirus (HEV71) is currently occurring in Sarawak, Malaysia. Most cases have uncomplicated hand, foot and mouth disease (HFMD), but a small number include neurological disease. Mary Jane Cardosa (University of Malaysia) told *TLID*, "for the first time, we are looking very carefully at how the viruses change with time over the period of the outbreak and we see that the dominant genogroup at the beginning of the outbreak was a C genogroup virus (sub genogroup C1), but this has now given way to another B genogroup virus (tentatively named subgenogroup B5), and may represent an emerging new sub-genogroup. Since the subgenogroup C1 strains have appeared sporadically throughout the 5 years of our surveillance, I think that it probably does not have a very high epidemic potential". The first B5 virus was isolated early in the outbreak from a child from a bazaar town not far from the Indonesian border. "I am not implying that Indonesia is a source of new viruses, merely that these viruses are not necessarily new, but not recognised before because of a lack of interest in studying their evolution", Cardosa explains. "We realised from the surveillance programme we had put inplace in 1998 that this year would potentially be a year when we would see HEV71 HFMD again. So early in the year, the Sarawak Health department sent out reminders to all their health providers to raise their index of suspicion about central nervous system disease that might be related to HEV71. They also reminded the public about personal hygiene being important in curbing the spread of this virus. The upshot of it is that there is calm and the number of cases reported by our sentinel clinics seems to be coming down. Ironically, all this public fear about SARS is also helping to reduce transmission of HEV71."

An outbreak of dengue (serotype 2) in north Queensland was first identified by a cluster of three locally acquired cases in the last week of January 2003. Since then the number of cases have risen quite dramatically and continues to spread across the state. As of April 10, there are 245 confirmed cases but no cases of dengue haemorrhagic fever (DHF). Vector control (source reduction, larviciding and adulticiding) has been carried out in accordance with a comprehensive Dengue Fever Management plan. In early March 2003 the Director of Public Health in Nauru, the Pacific island at the centre of a refugee crisis, confirmed an outbreak of dengue. The first case reported in mid February proved positive for IgM to dengue, as did the two following cases. There is no information on the serotype of any of the confirmed cases. There have been reports of a larger outbreak in the refugee camp on the island but as of April 10, there have been fewer than ten cases of confirmed DHF, and no deaths on the whole island. In terms of clinically diagnosed cases only five refugees were admitted to hospital with dengue symptoms---one child with bleeding manifestations, and four adults.
